Compared to PDT alone, photodynamic immunotherapy mediated by prodrug vesicles enhanced the immune response against CT26 and 4T1 tumor models and significantly inhibit tumor recurrence, especially for the IDO-overexpressing CT26 tumors. This evidence concerns the gene IDO1 and neoplasm.